Klein, S R
Piya, S
Lu, Z
Xia, Y
Alonso, M M
White, E J
Wei, J
Gomez-Manzano, C
Jiang, H
Fueyo, J
Article History
Received: 5 September 2014
Revised: 5 November 2014
Accepted: 5 December 2014
First Online: 26 January 2015
Competing interests
: Dr Fueyo and Dr Gomez-Manzano are funders of DNAtrix Inc., a company with interest in the clinical development of Delta-24-RGD as a therapeutic tool.